A Common Sleeping Pill May Reduce the Buildup of Alzheimer’s Proteins, Study Finds

By: | January 3rd, 2025

medicine

Image by Pixabay

We all value a restful night’s sleep—not just for the rejuvenation it provides but also for its significant impact on overall well-being. Emerging studies highlight how sleep plays a vital role in maintaining brain health and reducing the risk of conditions like Alzheimer’s disease.

Breakthrough in Alzheimer’s Research

A recent study published in the Annals of Neurology suggests that a common sleeping pill may help reduce the buildup of proteins linked to Alzheimer’s disease. Researchers found that suvorexant, a medication commonly prescribed for insomnia, lowered levels of amyloid-beta and tau proteins in the cerebrospinal fluid of healthy adults.

Amyloid-beta and tau proteins are known to form plaques and tangles in the brain, which are associated with cognitive decline and memory loss. While more research is needed, these findings indicate that suvorexant could potentially serve as a preventive treatment for Alzheimer’s.

The Connection Between Sleep and Brain Health

This discovery highlights the complex relationship between sleep quality, medication, and brain health. It emphasizes that prioritizing quality sleep can offer benefits that extend well beyond merely feeling refreshed.

However, it is essential to note that Suvorexant should only be used under medical supervision due to potential side effects. While this study offers promising evidence, further research is required to confirm the medication’s long-term safety and efficacy.

Nidhi Goyal

Nidhi is a gold medalist Post Graduate in Atmospheric and Oceanic Sciences.

More articles from Industry Tap...